Title : Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro.

Pub. Date : 2016 Mar

PMID : 26998043






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Currently, the first-line treatment of diabetes is based on metformin, which is an inducer of AMP-activated protein kinase (AMPK) and belongs to the biguanide class of pharmaceuticals. Biguanides protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
2 Currently, the first-line treatment of diabetes is based on metformin, which is an inducer of AMP-activated protein kinase (AMPK) and belongs to the biguanide class of pharmaceuticals. Biguanides protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens